Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
CBIO compared with DMRA: revenue, margins and what each company keeps, and the suppliers and customers both name
CBIO
Crescent Biopharma, Inc.
Change
Mkt cap
Revenue
Revenue
DMRA
Damora Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
CBIO
Crescent Biopharma, Inc.
vs
DMRA
Damora Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
CBIO, solid
DMRA, dashed
CBIO
Crescent Biopharma, Inc.
Change
13.80
▲
+6.68%
· post 13.28
Mkt cap
$502.9M
Revenue
$1M
Q1 FY26
DMRA
Damora Therapeutics, Inc.
Change
23.56
▲
+7.78%
· post 23.56
Closed
Nov 6 '26
Mkt cap
$1.5B
Revenue
—
vs
Compare
Closed
Nov 6 '26
CBIO
Crescent Biopharma, Inc.
vs
DMRA
Damora Therapeutics, Inc.
13.80
▲
+6.68%
post 13.28
Price
23.56
▲
+7.78%
post 23.56
$502.9M
Mkt cap
$1.5B
Q1 FY26
$1M
Revenue
—
Change
Change
CBIO
13.80
▲
+6.68%
vs
DMRA
23.56
▲
+7.78%
Closed
Nov 6 '26